FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Commodities

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileZepp Health Corporation
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
ZEPP
Zepp Health Corporation Stock AnalysisComprehensive stock analysis for Zepp Health Corporation (ZEPP) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisZEPP
ZEPP
Zepp Health Corporation
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
ZEPP
  1. Home
  2. Stocks
  3. Zepp Health Corporation
FRC Top Pick· Our analysts’ highest-conviction stocksSee all Top PicksAll Top Picks

Zepp Health Corporation

FRC Coverage
🇺🇸ZEPP•NYSE

Zepp Health Corporation

FRC Coverage
🇺🇸ZEPP•NYSE
Sentiment

Your view on ZEPP

Sentiment
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

*Zepp Health Corporation has paid FRC a fee for research coverage and distribution of reports.

About Zepp Health Corporation

Industry
Consumer Electronics
Sector
Technology
CEO
Wang Huang
Headquarters
Edisonweg 44 – B08 | Gorinchem, Zuid-Holland, Gorinchem, Zuid-Holland, NL
Industry
Consumer Electronics
Sector
Technology
CEO
Wang Huang
Headquarters
Edisonweg 44 – B08 | Gorinchem, Zuid-Holland, Gorinchem, Zuid-Holland, NL
Description

Zepp Health Corporation operates as a smart wearable and health technology company worldwide. The company empowers users to live lives by optimizing health, fitness, and wellness journeys through its consumer brands, Amazfit, Zepp Clarity, and Zepp Aura.

The company through its proprietary Zepp Digital Management Platform, which includes the Zepp OS, AI chips, biometric sensors, and data algorithms, delivers cloud-based 24/7 actionable insights and guidance to help users attain wellness goals.

The company offers smart bands, watches, scales, and rings; and associated accessories, smart hearable products, sportswear, home appliances, and smart watch accessories.

It also provides Zepp Aura, a real-time, personalized sound health solution offering health management, including emotional regulation and sports performance optimization; and provides charts and graphs to display analysis of the activity and biometric data collected from users through its Zepp Life and Zepp mobile apps.

It offers its products under the Amazfit and Zepp brand names in approximately 90 countries.

FRC Research
Rating
Fair Value Estimate
US$••.••
Members only

Premiumization Gains Traction as Global Smartwatch Shipments Contract

Report · Oct 6, 2026

Sign in to view

FRC Research
Rating
Fair Value Estimate
US$••.••
Members only

Premiumization Gains Traction as Global Smartwatch Shipments Contract

Report · Oct 6, 2026

Sign in to view

FRC Research

Research Reports

FRC analyst coverage and recommendations.

Research Reports

10 reports

*Zepp Health Corporation has paid FRC a fee for research coverage and distribution of reports.

Oct 6, 2026

Premiumization Gains Traction as Global Smartwatch Shipments Contract

We reiterate our BUY rating, and lower our fair value estimate from $53.01 to $43.86/share.

Thumbnail for Premiumization Gains Traction as Global Smartwatch Shipments Contract
Jul 22, 2026

Outgrowing the Market, Trading Below Liquid Assets

Zepp Health Corporation reported flat EPS of ($0.08) and lowered its FY2026 revenue growth forecast to 21% after Q2 guidance came in below expectations.

Thumbnail for Outgrowing the Market, Trading Below Liquid Assets
Apr 16, 2026

Strong Execution, Deep Discount: Market Missing the Turnaround

Zepp Health Corporation expects Q1-2026 revenue of $50–55M, driven by new product launches and a positive EPS outlook for 2026.

Thumbnail for Strong Execution, Deep Discount: Market Missing the Turnaround
    1
  • 1
  • 2
  • 3
  • 4

Past Reports

Historical coverage archive.

1 report
Nov 23, 2023

A Leading Smartwatch Maker Trading Below Liquid Assets - Initiating Coverage

PDF

Analyst Notes

Ongoing commentary and updates from FRC analysts.

9 notes

*Zepp Health Corporation has paid FRC a fee for research coverage and distribution of reports.

Apr 20, 2026· 7 months agoLatest

Company announcement

Launches Amazfit Cheetah 2 Pro (All figures in US$)

FRC Analyst's Comment

Amazfit’s Cheetah 2 Pro is a marathon-focused smartwatch competing with mid-to-premium running watches from Apple, Garmin, and others. It offers coaching plans, tracks key fitness data like heart rate and stamina, provides accurate GPS tracking, and has a lightweight but durable build, with about 29 hours of GPS battery life. It also supports major fitness apps. Early reviews suggests it delivers strong value at around $449 with many high-end features, but it is still less refined than Garmin’s ecosystem. Overall, we believe it looks like a solid, affordable option for serious runners, and a competitive addition to Zepp’s portfolio, though it still needs time to prove itself against established leaders.

We are anticipating Q1 results next month. In 2025, revenue rose 41% YoY to $259M, and EPS improved from ($0.29) to ($0.16). With recent product launches, we expect EPS to turn positive this year, potentially ending a five-year streak of losses. ZEPP trades at 0.45x forward revenue vs the sector average of 3.27x, an 86% discount.

Feb 9, 2026· 9 months ago

Company announcement

Partners with Olympic Medalist Josh Kerr

FRC Analyst's Comment

Zepp has partnered with Scottish middle-distance runner Josh Kerr, a gold medalist at the 2023 World Championships, silver medalist at the 2024 Olympics, and bronze medalist at the 2020 Olympics. Kerr joins an extensive roster of athletes promoting Zepp’s products, providing a strong testimonial and real-world validation of its wearables. Q3-2025 revenue was up 78% YoY, and management expects Q4 revenue to grow 40% YoY, with results due in the coming weeks. Notably, we anticipate EBITDA turning positive, representing a key milestone for the company.

Jan 12, 2026· 10 months ago

Company announcement

New products/concepts

FRC Analyst's Comment

Last week, Zepp Health attended CES 2026 in Las Vegas, one of the world’s largest tech shows, where it unveiled new products and upcoming concepts. As we noted last week, Zepp’s latest launch includes the Amazfit Active Max, a mid-tier, fitness-focused smartwatch that competes with budget- to mid-range offerings from Fitbit (NASDAQ: GOOGL), Garmin (NYSE: GRMN), and Samsung (KOSE: 005930). Zepp also showcased new concepts, including a food camera that tracks meals and links them to training and recovery, and smart glasses that display pace, heart rate, and navigation in a runner’s view for safer, hands-free workouts. While no other major wearables company currently offers these products, we note that they may be developing similar features. The key takeaway is that Zepp is actively innovating to stay ahead.

    1
  • 1
  • 2
  • 3

Media

Infographics, videos, and posts covering the company.

X (Twitter)

2 posts
Fundamental Research Corp.
Fundamental Research Corp.
@FRCorp
·Follow

*Disseminated on behalf of Zepp Health Corporation 💸 In 2025, revenue rose 41% YoY to $259M, exactly in line with our estimate, driven by 30% growth in unit sales vs. 4% growth in global smartwatch shipments, and a 16% increase in selling prices. 📈 Growth was driven by new  Show more

Image
11:05 PM · Apr 29, 2026
0
Reply
Read more on X
Fundamental Research Corp.
Fundamental Research Corp.
@FRCorp
·Follow

✨ Zepp Health combines a growing premium product lineup with a strong liquidity position. 🔎 The company trades at just 0.10x forward revenue, a 97% discount to its sector average. 💻 Access the full report with analyst insights at researchfrc.com/content/report… *Based on a report  Show more

Image
1:14 AM · Oct 18, 2026
1
Reply
Read more on X
Financial Data

Stock Data

Price chart, volume, and trading data.

FRC Analyst Fair Value

FRC's analysts' fair value estimate and rating, from their research on the company.

About this section

FRC's fair value estimate for Zepp Health Corporation, and the rating behind it. ZEPP last traded at $2.54; the estimate is read against that market price. Set by FRC's analysts in their research on the company: the current estimate, the rating, and when it was last revised. Included with a free account.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Zepp Health Corporation. Starting points for Zepp Health Corporation: EPS -$304.63, beta 1.93 — an Consumer Electronics name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for Zepp Health Corporation. Zepp Health Corporation does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Zepp Health Corporation. Trailing twelve-month EPS for Zepp Health Corporation stands at -$304.63. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Third partyAs of Nov 18, 2026 · CNY

Price targets, ratings and estimates published by outside analysts. Not FRC research, not a recommendation, and not the FRC Fair Value: that is FRC's proprietary model, built on the cash a company generates.

Current price

—

live quote

Analysts' target

$12.00

average of analysts' targets

 

$12.00

Low $12.00

Median $12.00

High $12.00

 

Earnings Estimate

EPSCurrent QtrDec 2021Next QtrMar 2022Current YearFY Dec 2026Next YearFY Dec 2027
Avg. estimateCNY 9.43CNY 1.58-CNY 0.70-CNY 0.28
Low estimateCNY 9.43CNY 1.58-CNY 0.70-CNY 0.28
High estimateCNY 9.43CNY 1.58-CNY 0.70-CNY 0.28
No. of analysts1111
Year-ago EPS——-CNY 283.041—
Growth————

1Year-ago EPS includes one-time items; growth not shown.

Revenue Estimate

RevenueCurrent QtrDec 2021Next QtrMar 2022Current YearFY Dec 2026Next YearFY Dec 2027
Avg. estimateCNY 1.86BCNY 961.18MCNY 2.13BCNY 2.27B
Low estimateCNY 1.86BCNY 961.18MCNY 2.13BCNY 2.27B
High estimateCNY 1.86BCNY 961.18MCNY 2.13BCNY 2.27B
No. of analysts1111
Year-ago revenue——CNY 1.82B—
Growth——+17.2%—
Recent analyst actions1 rating and price-target change, latest Jul 9, 2025 — with the analyst, firm and source

Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep from Benzinga; as of Nov 18, 2026. Not FRC research or a recommendation.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Zepp Health Corporation. Zepp Health Corporation has reported as a listed company since 2018. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold ZEPP20 companies · 1 funds
Compare ZEPP with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis

Peer companies

Market cap

  • ARAIArrive AI Inc.Software - Application$3M
  • BWBabcock & Wilcox Enterprises, Inc.Industrial - Machinery$630M
  • EXFYExpensify, Inc.Software - Application$165M
  • KULRKULR Technology Group, Inc.Industrial - Machinery$74M
  • STEMStem, Inc.Renewable Utilities$19M
  • SVCOSilvaco Group, Inc. Common StockSoftware - Application$237M
  • TROOTROOPS, Inc.Financial - Credit Services$160M
  • TTECTTEC Holdings, Inc.Information Technology Services$152M

More Consumer Electronics companies

  • SONYSony Group CorporationNYSE$161.1B
  • SSNLFSamsung Electronics Co., Ltd.OTC$383.2B
  • SWDHFSkyworth Group LimitedOTC$984M
  • SWDHYSkyworth Group LimitedOTC$780M
  • TBCHTurtle Beach CorporationNASDAQ$286M
  • TCLHFTCL Electronics Holdings LimitedOTC$4.1B
  • UEICUniversal Electronics Inc.NASDAQ$78M
  • VTEPFVidendum PlcOTC$19M
  • VUZIVuzix CorporationNASDAQ$102M
  • WLDSWearable Devices Ltd.NASDAQ$3M
  • WLDSWWearable Devices Ltd.NASDAQ$9M
  • XIACFXiaomi CorporationOTC$118.3B

ETFs holding Zepp Health Corporation

% of the fund

  • SNSRGlobal X - Internet of Things ETF$193M in assets0.04%

Largest holders first, then the funds most concentrated in ZEPP.

Open Comparable Analysis
Ownership & News

Institutional Ownership

Which funds and firms own the stock.

About this section

Which institutions hold Zepp Health Corporation, and how their positions are changing. At a $36.4M market value, institutional positions materially move Zepp Health Corporation's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.

Insider Trading

Recent buying and selling by company executives.

About this section

Buying and selling by Zepp Health Corporation executives and directors. Shares of Zepp Health Corporation have traded between $2.13 and $61.85 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for Zepp Health Corporation. Coverage tracks Zepp Health Corporation within Consumer Electronics (Technology). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Zepp Health Corporation.

News

Latest Market News